Statements (28)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:drug
|
| gptkbp:bfsLayer |
4
|
| gptkbp:bfsParent |
gptkb:Cymbalta
|
| gptkbp:activities |
gptkb:drug
|
| gptkbp:appointed_by |
oral capsule
|
| gptkbp:approves |
gptkb:2004
gptkb:FDA |
| gptkbp:clinical_trial |
approximately 50%
|
| gptkbp:developed_by |
gptkb:Eli_Lilly_and_Company
|
| https://www.w3.org/2000/01/rdf-schema#label |
Duloxetine hydrochloride
|
| gptkbp:ingredients |
C18 H19 NOS
|
| gptkbp:interacts_with |
gptkb:beer
anticoagulants MAO inhibitors NSAI Ds |
| gptkbp:is_used_for |
chronic pain
fibromyalgia generalized anxiety disorder major depressive disorder |
| gptkbp:marketed_as |
gptkb:Cymbalta
|
| gptkbp:side_effect |
dizziness
fatigue nausea insomnia constipation dry mouth sweating |
| gptkbp:type_of |
136434-34-9
|